Related Experiment Video
Updated: Jan 8, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Rethinking acute nicotine self-administration in inhaled tobacco products: A randomized clinical trial with ENDS in
Mario El Hourani1, Soha Talih1, Rola Salman1
1Mechanical Engineering Department, Maroun Semaan Faculty of Engineering and Architecture, American University of Beirut, Bliss Street, PO. Box 11-0236, Beirut, Lebanon.
Background:
Puffing behavior is often interpreted through a nicotine titration model, which posits that individuals adjust puffing to achieve the central nervous system effects of nicotine. This model has been invoked frequently to explain the phenomenon of "compensation," in which people increase puffing intensity when using reduced-nicotine products. However, puffing patterns may also be governed by sensory feedback in the upper airways. This study tests that hypothesis using electronic nicotine delivery systems (ENDS) as a model.
Design:
Within-subject, double-blind clinical study using a puff-by-puff switching protocol.
Setting:
Clinical Aerosol Technology Lab, American University of Beirut; December 2024.
Interventions:
Ten adults who consume both ENDS and cigarettes completed three randomized directed puffing bouts during a single clinical lab visit. In each bout, they alternated puffs between two identical ENDS devices differing by one design factor: (1) power (20W vs 40W, 0mg/ml nicotine); (2) power (20W vs 40W, matched nicotine flux); (3) PG:VG ratio (30:70 vs 70:30).
Outcomes:
Puff topography and sensory feedback (mouthful, draw effort, throat hit) measured on a puff-by-puff basis.
Results:
Puff duration responded immediately and reversibly to changes in sensory feedback. At higher power, participants reported stronger mouthful, easier draw, and took shorter puffs regardless of nicotine content (p < .05). At matched flux, computed nicotine dose was lower at 40W than 20W (p < .01). PG:VG effects were also significant.
Conclusions:
Puffing behavior appears to be driven by sensory cues, not delayed nicotine effects-highlighting an underused regulatory pathway: targeting product design features that shape perception.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...